GT200900045A - Sales de bencimidazolilo piridilo eteres y las formulaciones del mismo - Google Patents

Sales de bencimidazolilo piridilo eteres y las formulaciones del mismo

Info

Publication number
GT200900045A
GT200900045A GT200900045A GT200900045A GT200900045A GT 200900045 A GT200900045 A GT 200900045A GT 200900045 A GT200900045 A GT 200900045A GT 200900045 A GT200900045 A GT 200900045A GT 200900045 A GT200900045 A GT 200900045A
Authority
GT
Guatemala
Prior art keywords
salts
formulations
bencimidazolil
piridile
eternal
Prior art date
Application number
GT200900045A
Other languages
English (en)
Inventor
Gullapalli Rampurna
Hashash Ahmad
Kangwen L Lin
Augustus O Okhamafe
Sy Eduardo
Piotr H Karpinski
Eric M Loeser
Sutton Paul Allen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200900045A publication Critical patent/GT200900045A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PROPORCIONAN SALES DE BENCIMIDAZOLIL-PIRIDIL-ETERES, EN PARTICULAR SALES DE {1-METIL-5-[2-(TRIFLURO-METIL-1H-IMIDAZOL-2-IL)-PIRIDIN-4-ILOXI]-1H-BENZO-IMIDAZOL-2-IL}- (4-TRIFLURO-METIL-FENIL)-AMINA. SE PROPORCIONA COMPOCICIONES Y FORMULACIONES QUE INCLUYEN ESTAS SALES Y TENSOACTIVOS, ASÍ COMO MÉTODOS PARA LA PREPARACIN DE ESTAS COMPOCICIONES Y FORMULACIONES.
GT200900045A 2006-08-30 2009-02-27 Sales de bencimidazolilo piridilo eteres y las formulaciones del mismo GT200900045A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84117706P 2006-08-30 2006-08-30
US95446607P 2007-08-07 2007-08-07

Publications (1)

Publication Number Publication Date
GT200900045A true GT200900045A (es) 2010-06-14

Family

ID=39027583

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200900045A GT200900045A (es) 2006-08-30 2009-02-27 Sales de bencimidazolilo piridilo eteres y las formulaciones del mismo

Country Status (34)

Country Link
US (2) US8202998B2 (es)
EP (1) EP2059518B1 (es)
JP (1) JP5279712B2 (es)
KR (1) KR20090043542A (es)
CN (1) CN101516870B (es)
AT (1) ATE504584T1 (es)
AU (1) AU2007290388B2 (es)
BR (1) BRPI0716243A2 (es)
CA (1) CA2660376C (es)
CL (1) CL2007002533A1 (es)
CO (1) CO6150180A2 (es)
CY (1) CY1112187T1 (es)
DE (1) DE602007013774D1 (es)
DK (1) DK2059518T3 (es)
ES (1) ES2360968T3 (es)
GT (1) GT200900045A (es)
HK (1) HK1131613A1 (es)
HR (1) HRP20110311T1 (es)
IL (1) IL196811A (es)
JO (1) JO2702B1 (es)
MA (1) MA30711B1 (es)
MX (1) MX2009002279A (es)
MY (1) MY161829A (es)
NO (1) NO20091236L (es)
NZ (1) NZ574620A (es)
PE (2) PE20080766A1 (es)
PL (1) PL2059518T3 (es)
PT (1) PT2059518E (es)
RU (1) RU2457206C2 (es)
SI (1) SI2059518T1 (es)
TN (1) TN2009000068A1 (es)
TW (1) TW200819438A (es)
WO (1) WO2008027523A2 (es)
ZA (1) ZA200900664B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080766A1 (es) * 2006-08-30 2008-06-15 Novartis Ag Sales de benzimidazolil piridil eteres y formulaciones que las contienen
MY148438A (en) * 2007-03-02 2013-04-30 Novartis Ag Solid forms of a raf kinase inhibitor
EP2288354A1 (en) * 2008-06-13 2011-03-02 Novartis AG Substituted benzimidazoles for neurofibromatosis
WO2010088335A1 (en) * 2009-01-29 2010-08-05 Novartis Ag Substituted benzimidazoles for the treatment of astrocytomas
WO2011044072A1 (en) 2009-10-05 2011-04-14 Novartis Ag Combination of raf-265 and an activator of ampk for use in the treatment of a proliferative disease
CN103237544A (zh) * 2010-12-03 2013-08-07 诺华有限公司 药物组合物
EP4069199B1 (en) * 2019-12-02 2024-01-17 Astrazeneca AB Solid pharmaceutical formulations of 6-(2-chloro-6-methylpyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
WO2022083741A1 (zh) * 2020-10-23 2022-04-28 上海辉启生物医药科技有限公司 吡唑并吡啶类化合物或其盐及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299108B2 (en) * 2002-03-29 2012-10-30 Novartis Ag Substituted benzazoles and methods of their use as inhibitors of raf kinase
MXPA04009541A (es) * 2002-03-29 2005-01-25 Chiron Corp Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
US20060189619A1 (en) 2005-02-24 2006-08-24 Wyeth 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds
TWI387592B (zh) * 2005-08-30 2013-03-01 Novartis Ag 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法
US7731795B2 (en) 2005-12-02 2010-06-08 Clemson University Rhombohedral fluoroberyllium borate crystals and hydrothermal growth thereof for use in laser and non-linear optical applications and devices
PT2046292E (pt) * 2006-07-21 2010-04-26 Novartis Ag Formulações de éteres benzimidazolil-piridílicos
PE20080766A1 (es) 2006-08-30 2008-06-15 Novartis Ag Sales de benzimidazolil piridil eteres y formulaciones que las contienen

Also Published As

Publication number Publication date
ATE504584T1 (de) 2011-04-15
AU2007290388A1 (en) 2008-03-06
CA2660376A1 (en) 2008-03-06
US20100168060A1 (en) 2010-07-01
HRP20110311T1 (hr) 2011-08-31
WO2008027523A3 (en) 2008-04-10
EP2059518B1 (en) 2011-04-06
PE20080766A1 (es) 2008-06-15
PL2059518T3 (pl) 2011-09-30
US20120308651A1 (en) 2012-12-06
TN2009000068A1 (en) 2010-08-19
RU2009111384A (ru) 2010-10-10
JO2702B1 (en) 2013-03-03
EP2059518A2 (en) 2009-05-20
ZA200900664B (en) 2009-12-30
CY1112187T1 (el) 2015-12-09
TW200819438A (en) 2008-05-01
JP2010502622A (ja) 2010-01-28
PE20130814A1 (es) 2013-08-08
IL196811A (en) 2013-03-24
AU2007290388B2 (en) 2011-07-14
NO20091236L (no) 2009-03-27
US8202998B2 (en) 2012-06-19
BRPI0716243A2 (pt) 2013-09-03
PT2059518E (pt) 2011-07-11
NZ574620A (en) 2011-05-27
DK2059518T3 (da) 2011-05-16
MY161829A (en) 2017-05-15
IL196811A0 (en) 2009-11-18
CL2007002533A1 (es) 2008-02-08
HK1131613A1 (en) 2010-01-29
MX2009002279A (es) 2009-03-20
CA2660376C (en) 2014-04-15
JP5279712B2 (ja) 2013-09-04
KR20090043542A (ko) 2009-05-06
DE602007013774D1 (de) 2011-05-19
US8501785B2 (en) 2013-08-06
CN101516870A (zh) 2009-08-26
CO6150180A2 (es) 2010-04-20
WO2008027523A2 (en) 2008-03-06
MA30711B1 (fr) 2009-09-01
ES2360968T3 (es) 2011-06-10
CN101516870B (zh) 2013-09-11
SI2059518T1 (sl) 2011-06-30
RU2457206C2 (ru) 2012-07-27

Similar Documents

Publication Publication Date Title
GT200900045A (es) Sales de bencimidazolilo piridilo eteres y las formulaciones del mismo
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
ECSP099250A (es) USO DE 2-6-(3-amino-piperidin-1-Il)-3-metil-2,4-dioxo-3,4-dihIdro-2H-pIrimidin-1-IlmetIL-4-fluoro-benzonitrilo
ECSP12011935A (es) Triazolopiridinas
CR20140275A (es) Triazolopiridinas sustituidas
CL2008002006A1 (es) Compuestos derivados de morfolin pirimidina, composicion farmaceutica, y su uso como inhibidores de la m-tor-quinasa para el tratamiento de l a inflamacion, cancer, enfermedades inmunes, enfermedad obstructiva pulmonar, enfermedad cardiovascular.
UY30500A1 (es) Compuestos de azabencimidazolilo
NI201100108A (es) Nuevas pirazol - 4 - n - alcoxicarboxamidas como microbicidas.
UY31189A1 (es) Compuestos heterocíclicos
SV2011003855A (es) Heteroarilos sustituidos
CU20120078A7 (es) Composiciones para tratar náusea y vómito centralmente mediados
CR9786A (es) Compuestos de bencimidazol-tiofeno
DOP2009000215A (es) Administracion semanal de inhibidores de peptidasa de pipeptidilo
UY31484A1 (es) Piperidinas heteroaril-sustituidas
DOP2013000244A (es) Triazolopiridinas
ECSP12012338A (es) Triazolopiridinas sustituidas
NI201100096A (es) Lactamas como inhibidores de beta secretasa.
UY32387A (es) Ciclopentanodionas herbicidamente activas, derivados, procesos para su preparación, composiciones que las comprenden y usos de las mismas
UY30307A1 (es) Moduladores de mglur5 vi
CL2009001804A1 (es) Uso de un copolimero de vinilamina-vinilformamida y un portador para preparar una composicion destinada a fortalecer las fibras queratinosas.
SV2010003752A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
CL2012000508A1 (es) Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas.
AR058047A1 (es) Administracion de inhibidores de dipeptidil peptidasa
UY29804A1 (es) Quinolinas de alquilnitrilo
GT201100039A (es) Agentes antifúngicos